Free shipping on all orders over $ 500

Glucagon Receptor Glucagon Receptor

Cat.No.  Name Information
M10249 Teduglutide Teduglutide is a glucagon-like peptide-2 (GLP-2) analogue used for the treatment of short-bowel syndrome.
M25470 Mazdutide Mazdutide (IBI362, LY3305677) is a novel glucagon-like peptide-1 (GLP-1) and glucagon receptor dual agonist.
M25390 Dapiglutide Dapiglutide (ZP7570) is a long-acting glucagon-like peptide-1 receptor 1R (GLP-1R)/Glucagon-like peptide-2 receptor (GLP-2R) dual agonist.
M21658 Taspoglutide Taspoglutide is a long-acting glucagon-like peptide 1 (GLP-1) receptor agonist developed for treatment of type 2 diabetes, with an EC50 value of 0.06 nM.
M21371 Tirzepatide Tirzepatide (LY3298176) is a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor dual agonist with potential use in type 2 diabetes research.
M13972 Semaglutide TFA Semaglutide TFA, a long-acting GLP-1 analogue, is a glucagon-like peptide-1 (GLP-1) receptor agonist. Semaglutide TFA has the potential for type 2 diabetes treatment.
M13971 MK 0893 MK 0893 is a potent and selective glucagon receptor antagonist with an IC50 of 6.6 nM.
M13970 Lixisenatide acetate Lixisenatide acetate is a glucagon-like peptide-1 (GLP-1) receptor agonist that can be used in the treatment of type 2 diabetes mellitus (T2DM).
M13968 GLP-1(7-36), amide acetate GLP-1(7-36), amide acetate is a major intestinal hormone that stimulates glucose-induced insulin secretion from β cells.
M13967 GLP-1(7-37) acetate GLP-1(7-37) acetate is an intestinal insulinotropic hormone that augments glucose induced insulin secretion.
M13966 Adomeglivant Adomeglivant (LY2409021) is a potent, selective glucagon receptor (GluR) allosteric antagonist. Adomeglivant is widely used in the research for type 2 diabetes mellitus.
M11428 LSN3318839 LSN3318839 is an orally active allosteric modulator of glucagon-like peptide-1 receptor (GLP-1R).
M11319 GLP-1(7-36), amide TFA TFA is a major intestinal hormone that stimulates insulin secretion by pancreatic beta cells in response to glucose.
M11207 GLP-1(7-37) Glp-1 (7-37) is an intestinal insulin hormone that enhances glucose-induced insulin secretion.
M10311 Danuglipron (PF-06882961) Danuglipron (PF-06882961) is a potent, orally bioavailable agonist of the glucagon-like peptide-1 receptor (GLP-1R) agonist.
M10249 Teduglutide Teduglutide is a glucagon-like peptide-2 (GLP-2) analogue used for the treatment of short-bowel syndrome.
M10144 NNC0640 NNC0640 is a potent, negative allosteric modulator (NAM) of human G-protein-coupled glucagon receptor (GCGR) with IC50 of 69.2 nM.
M10089 Avexitide (Exendin 9-39) Avexitide (Exendin 9-39) is a specific and competitive GLP-1 receptor antagonist.
M10035 Semaglutide Semaglutide (Rybelsus, Ozempic, NN9535, OG217SC, NNC 0113-0217) is a long-acting human GLP-1 analog, it is also a GLP-1 receptor agonist with the potential for the treatment of type 2 diabetes mellitus (T2DM).
M10034 Exendin-4 Exenatide (AC2993) is a first-in-class glucagon-like peptide 1 (GLP-1) receptor agonist consisting of 39 amino acids.
M9749 Cotadutide acetate Cotadutide acetate is a potent peptide dual agonist of glucagon-like peptide-1 (GLP-1) and glucagon receptor, with EC50 values of 6.9 pM and 10.2 pM, respectively.



Contact Us

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2020 AbMole BioScience. All Rights Reserved.